dsm-firmenich reports Q3 2026 trading update

dsm-firmenich delivered Q3 2026 like-for-like sales growth of 5%, consistent with year-to-date performance, with Adjusted EBITDA margin expanding sequentially to 20.4%. The company raised its FY 2026 outlook for LFL sales growth to around 5% (from 2-4%) and completed a €540 million share repurchase program. All three business units contributed positively, with Perfumery & Beauty leading at 8% growth.